Zacks Investment Research Downgrades Vaxxinity (NASDAQ:VAXX)

Vaxxinity (NASDAQ:VAXX – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Thursday, Zacks.com reports. According to Zacks, “Vaxxinity Inc. is a biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Vaxxinity Inc. is based in DALLAS, Texas. “ Vaxxinity […]

Related Keywords

United States , Dallas , Texas , , Geode Capital Management , Virtu Financial , Zacks Investment Research , Investment Advisers , Vaxxinity Company Profile Get Rating , Managers Group , Vaxxinity Inc , Millennium Management , Get Rating , Capital Management , Company Profile , Lewy Body , Vaxxinity , Nasdaq Vaxx , Vaxx , Medical , Downgrade ,